Gufic BioSciences Ltd

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent upgrade from a Sell to a Strong Sell rating by MarketsMOJO on 17 Nov 2025, the stock’s price action and technical indicators reveal a cautious outlook for investors navigating this evolving landscape.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 March 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant point in its recent price trajectory. The stock has been on a declining path for the past three days, cumulatively losing 2.15% in returns, reflecting ongoing pressures within the company’s performance metrics and market valuation.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.268.65 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Shares of Gufic BioSciences Ltd have declined to a fresh 52-week low, touching an intraday low of ₹274.85, marking a significant milestone in the stock’s ongoing downward trajectory. This new low comes amid a broader market decline and reflects persistent pressures on the company’s financial performance and valuation metrics.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.273.1 today, marking a significant decline amid a broader market downturn. The stock’s recent performance reflects ongoing pressures, with the share price falling below all major moving averages and underperforming its sector peers.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 February 2026, providing investors with the latest insights into its performance and outlook.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.280.7 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.

Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.283.8 today, marking a significant decline in its share price amid ongoing pressures. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s equity performance.

Gufic BioSciences Ltd experienced a notable decline today, hitting an intraday low of Rs 284.1, reflecting sustained price pressure amid broader market dynamics. The stock underperformed its sector and the benchmark Sensex, continuing a recent downward trend that has weighed on investor sentiment.

Shares of Gufic BioSciences Ltd have declined to a fresh 52-week low, closing just 0.78% above the lowest price recorded in the past year at Rs 285. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s share price underperforming both its sector and broader market indices.

Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a Strong Sell by MarketsMOJO reflects deteriorating price action and weakening market sentiment within the Pharmaceuticals & Biotechnology sector.

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Gufic BioSciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price action and technical indicators reveal a landscape of cautious investor sentiment and potential inflection points.

Gufic BioSciences Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 6.44% higher than its previous close, signalling a strong start amid positive market sentiment in the Pharmaceuticals & Biotechnology sector.